Scarica l'app Stockscreener
73.27
4.56%
-3.50
Pre-mercato:
72.81
-0.46
-0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
[8-K] PTC THERAPEUTICS, INC. Reports Material Event - Stock Titan
PTC Therapeutics prices convertible notes for refinancing - MSN
PTC Therapeutics (PTCT) Launches $500M Convertible Notes Offerin - GuruFocus
PTC Therapeutics Prices $500 Million Notes Offering - marketscreener.com
Biotech PTC sells $500M 0% notes at 40% premium to stock - Stock Titan
PTC Therapeutics Prices $500 Million 0% Convertible Senior Notes Due 2031 - TradingView
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes - TradingView
PTC Therapeutics Plans $500 Million Convertible Notes Offering to Refinance 2026 Notes - marketscreener.com
PTC Therapeutics plans $500M notes to refinance 2026 debt, buy stock - Stock Titan
PTC Therapeutics Q1 earnings call highlights - MSN
PTC Therapeutics Insider Sold Shares Worth $1,595,775, According to a Recent SEC Filing - Moomoo
PTC Therapeutics climbs after guidance hike - MSN
96,860 Shares in PTC Therapeutics, Inc. $PTCT Acquired by Castleark Management LLC - MarketBeat
Insider Sell: Eric Pauwels Sells 21,277 Shares of PTC Therapeuti - GuruFocus
PTC Therapeutics CBO Eric Pauwels sells $1.6 million in stock - Investing.com UK
PTC Therapeutics CBO Eric Pauwels sells $1.6 million in stock By Investing.com - Investing.com South Africa
PTC Therapeutics (PTCT) CBO sells shares under 10b5-1 trading plan - Stock Titan
Sector Gamma AS Sells 56,189 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC THERAPEUTICS INC (NASDAQ:PTCT) Scores Perfect 10/10 For Technical Breakout Setup - ChartMill
Fidelity affiliate seeks to sell PTCT (NASDAQ: PTCT) 17,566 shares on 06/10/2026 - Stock Titan
PTC Therapeutics upgraded at Jefferies on Sephience - MSN
Los Angeles Capital Management LLC Has $2.46 Million Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Key facts: PTC Therapeutics director resigns; posts record revenue - TradingView
PTC Therapeutics Director Resigns, Moves to Advisory Role - TipRanks
Alethia Young resigns from PTC Board, to serve as consultant - TradingView
PTC Therapeutics (NASDAQ: PTCT) director Alethia Young shifts to consultant role - Stock Titan
PTC Therapeutics Shares Rise After Upgrade From Citigroup - Moomoo
Transcript : PTC Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 09 - marketscreener.com
PTCT Raised by Citigroup -- Price Target Increased to $108 - GuruFocus
PTC Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Citigroup Upgrades PTC Therapeutics to Buy From Hold, Raise Price Target to $108 From $76 - marketscreener.com
PTC Therapeutics (PTCT) reports Q1 loss, tops revenue estimates - MSN
19,877 Shares in PTC Therapeutics, Inc. $PTCT Purchased by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - MarketBeat
A Look At PTC Therapeutics (PTCT) Valuation As Models Flag A Potential Discount - Sahm
Why The PTC Therapeutics (PTCT) Story Is Shifting As Sephience Assumptions Drive New Valuations - Yahoo Finance
Total operating expenses of PTC Therapeutics, Inc. – XETR:BH3 - TradingView
BI Asset Management Fondsmaeglerselskab A S Purchases 64,472 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Gross profit of PTC Therapeutics, Inc. – XETR:BH3 - TradingView
PTC Therapeutics Shareholders Back Board, Pay and Auditor - The Globe and Mail
Total debt per share of PTC Therapeutics, Inc. – XETR:BH3 - TradingView
PTC Therapeutics, Inc. Cash Flow – XETR:BH3 - TradingView
ETFs Investing in PTC Therapeutics, Inc. Stocks - TradingView
PTC Therapeutics, Inc. 8-K Filing June 2026 – Company Information, Stock Details, and SEC Compliance - Minichart
Precision Trading with Ptc Therapeutics Inc. (PTCT) Risk Zones - Stock Traders Daily
PTC Therapeutics (NASDAQ: PTCT) investors approve directors, auditor and pay at 2026 meeting - Stock Titan
Geode Capital Management LLC Boosts Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat
Gastroparesis Market Shows Strong Future Potential with Increasing Industry Investments by 2036 – DelveInsight | Vanda Pharma, Dr. Falk Pharma GmbH, Alfasigma S.p.A., PTC Therapeutics, CinDome Pharma - Barchart.com
Gastroparesis Market Shows Strong Future Potential with - openPR.com
PTC Therapeutics Drops 6.3% Amid Sector-Wide Selling - AlphaStreet
PTC Therapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus
BNP Paribas Financial Markets Has $62.95 Million Stock Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
Legal & General Group Plc Buys 124,923 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. $PTCT Shares Sold by Hillsdale Investment Management Inc. - MarketBeat
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):